Login
Open Demat Account
Open Demat A/C
Offerings
+
Research
Markets+
Talking Finance+
Support+
Media+
Partner Us+
Trade LoginReports LoginIFD Partner Login
Demo
Close Language Tab
Locate us
Languages
  • Home
  • Company Information
  • Max Healthcare Institute Ltd
M
Max Healthcare Institute Ltd Healthcare
₹ 1,264.60 -9.70 (-0.76%)
  • NSE
  • BSE

Overview

  • BSE Code 543220
  • NSE Symbol MAXHEALTH
  • ISIN Demat INE027H01010
  • Book Value (₹) 85.27
  • Face Value (₹) 10.00
  • Market Cap (₹ Cr.) 1,18,237.36
  • P/E (TTM) 156.53
  • EPS (TTM) 7.77
  • Div Yield (%) 0.12

Performance

Today’s Low 1,253.00
Today’s High 1,276.70

1,264.60
52W Low 836.60
52W High 1,314.30

1,264.60
Open 1,275.20
Prev. Close 1,274.30
Volume 16,43,450.00

Corporate Actions

Max Healthcare Institute Limited - Disclosure under SEBI Takeover Regulations
Apr 22, 2025

Abhay Soi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

About Max Healthcare Institute Ltd

Max Healthcare Institute Limited mainly supplies healthcare services via its primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals. It came into existence as as Infinitum Technologies Private Limited in 2001. It commenced its business in 2000 by setting up its first multi-speciality hospital, Max Medcentre, in Panchsheel Park, New Delhi. It continued its business growth and opened  Max Hospital, Pitampura, and Max Hospital, Noida, in 2002. In 2008, the company received Express Healthcare Awards for Excellence in Healthcare. During the subsequent year, it received the D L Shah National Award on 'Economics of Quality' by the Quality Council of India. In 2011, the company opened two more branches named Max Super Speciality Hospital, Bathinda and Max Super Speciality Hospital, Mohali. In 2017, Max Super Speciality Hospital, Saket, received accreditation from the Joint Commission International (JCI). 2020 saw the plan's implementation, which included combining Max India and Radiant's healthcare business with the corporation. The company was listed on BSE and NSE in the same year after an IPO. As of March 31, 2023, the company had 17 hospitals, a Bed Capacity of over 3,550 and over 4,800 clinicians.

Business Segments

The company earns revenue from only one business segment, i.e., Medical and Healthcare Services. Under this segment, the company supplies healthcare facilities comprising primary care clinics, secondary care hospitals/medical centres and tertiary care facilities. Subsidiaries As of March 31, 2023, the company had 9 subsidiaries, including one step-down subsidiary.
  • Hometrail Buildtech Private Limited:It is a wholly owned subsidiary that is currently running and operating two hospitals. Max Super Speciality Hospital, Bhatinda and Max Super Speciality Hospital, Mohali.
  • MHC Global Healthcare (Nigeria) Limited:This wholly-owned subsidiary offers consultation services to patients.
  • Max Lab Limited: It is a wholly-owned subsidiary of Max Healthcare. The organization is known for its expertise in the diagnostic industry.

Key Personnel

Abhay Soi, Chairman & Managing Director Abhay is the Promoter, Chairman and Managing Director of the company. He was the Promoter, Chairman and Managing Director of Radiant Life Care Private Limited prior to the acquisition and merger with Max Healthcare. Prior to Radiant, Abhay co-founded USD 350mn, a Special Situations Private Equity Fund, where he made investments across sectors such as Mining, Financial Services, Agri-processing, Retail, Paper & paperboard manufacturing, Textiles and Specialty Chemicals. Abhay has an MBA from European University, Belgium and a Bachelor in Arts from St. Stephen’s College, Delhi University.

Corporate Actions

The company has no history of bonus issues, stock splits and other corporate actions.

Management Outlook

  • Looking forward, the organization will core priority on expanding the width and depth of its services to serve the increasing number of patients while improving the quality of care.
  • The organization is optimistic about its aggressive plan to expand its bed capacity through various means, including brownfield, greenfield and asset-light models.
  • During FY 2023, it executed an ‘Agreement to Sell’ to purchase a piece of land in Ghaziabad adjacent to the hospital owned and operated by one wholly owned subsidiary, Crosslay Remedies Limited.
  • The organization anticipates commissioning the 300-bedded, built-to-suit facility at Dwarka in the latter half of FY24.
Founded: 2001
Chairman: Abhay Soi
Managing Director: Abhay Soi
Address: 167 Floor-1 Plot-167, Ready Money Mansion Worli, Mumbai, Maharashtra, 400018,
HO Tel: +91 22 2610 0461/ 62